Hyperuricemia and Incident Cardiovascular Disease and Noncardiac Vascular Events in Patients with Rheumatoid Arthritis

Abstract EN

Objective.

To evaluate whether hyperuricemia is a risk factor for cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA).

Methods.

A population-based inception cohort of patients diagnosed between 1980 and 2007 with adult-onset RA was assembled.

A comparison cohort of age- and sex-matched subjects without RA (non-RA) was also assembled.

All clinically obtained uric acid values were collected.

CVD and noncardiac vascular events were recorded for each patient.

Cox proportional hazards models were used to assess the impact of hyperuricemia on development of CVD, mortality, and noncardiac vascular disease.

Results.

In patients without RA, hyperuricemia was associated with heart failure (HR: 1.95; 95% CI: 1.13–3.39) and CVD (HR: 1.59; 95% CI: 0.99–2.55).

In patients with RA, hyperuricemia was not significantly associated with CVD but was significantly associated with peripheral arterial events (HR: 2.52; 95% CI: 1.17–5.42).

Hyperuricemia appeared to be more strongly associated with mortality among RA patients (HR: 1.96; 95% CI: 1.45–2.65) than among the non-RA subjects (HR: 1.57; 95% CI: 1.09–2.24).

Conclusion.

In patients with RA, hyperuricemia was a significant predictor of peripheral arterial events and mortality but not of CVD.